In addition, Casas showed that relocation of BiP to the plasma membrane could act as a signal receptor and activate downstream oncogenic pathways, thereby increasing cell proliferation and conferring chemoresistance in prostate and gastric cancer [56, 57]. The gene discussed is HSPA5; the disease is gastric cancer.